Updated on 2026/05/25

Information

 

写真a

 
FUYUNO YOKO
 
Organization
Kyushu University Hospital Dermatology Lecturer
School of Medicine Department of Medicine(Concurrent)
Title
Lecturer

Degree

Research History

  •  Kyushu University Hospital Dermatology  Lecturer 

    2025.4 - Present

  • Kyushu University  Lecturer 

    2025.4

      More details

    Country:Japan

Research Interests・Research Keywords

  • Research theme: dermatology

    Keyword: dermatology

    Research period: 2014.8

Papers

  • Cytokine profile of the stratum corneum in atopic dermatitis lesions differs between the face and the trunk

    Igawa Satomi, Matsunaka Hiroshi, Chiba Takahito, Higashi Yuko, Mizusawa Yuta, Ibusuki Atsuko, Murakami Yumi, Tsuji Gaku, Nakahara Takeshi, Kido-Nakahara Makiko, Kuba-Fuyuno Yoko

    Allergology International   74 ( 2 )   222 - 232   2025   ISSN:13238930 eISSN:14401592

     More details

    Language:English   Publisher:Japanese Society of Allergology  

    <p><i>Background:</i> Atopic dermatitis (AD) is a chronic inflammatory skin disease with intense pruritus. Dupilumab, an anti-IL-4 receptor alpha antibody, has been revealed to be highly effective against the symptoms of AD; however, dupilumab takes longer to improve facial dermatitis in some patients. We thus examined whether the cytokine profiles in AD lesions differ between different anatomical locations.</p><p><i>Methods:</i> Stratum corneum was collected by tape stripping from lesions of the forehead and abdomen of 24 patients with moderate to severe AD and at the same anatomical locations of 14 control subjects. These samples were then used to determine the expression profiles of Th1, Th2, and Th17 cytokines/chemokines by multiplex assay and immunocytochemistry.</p><p><i>Results:</i> We found that cytokines/chemokines in the stratum corneum differed in their expression between different anatomical areas in AD patients and also in healthy control subjects. The expression of Th1 and Th17 cytokines/chemokines such as IP-10, MIG, and IL-17 tended to be higher in the forehead than in the abdomen in the AD group. Regarding Th2 cytokines/chemokines, some (e.g., IL-13 and IL-33) were highly expressed in the abdomen, others (e.g., IL-4 and IL-31) were highly expressed in the forehead, and a third group (e.g., TARC and TSLP) did not differ significantly in their expression between the forehead and abdomen. These patterns of Th2 cytokines were almost identical in the stratum corneum of healthy individuals.</p><p><i>Conclusions:</i> Differences in cytokine/chemokine profiles in the stratum corneum between different anatomical areas might affect the responsiveness to AD treatment.</p>

    DOI: 10.1016/j.alit.2024.08.010

    Scopus

    CiNii Research

Presentations

MISC

Professional Memberships

  • 日本皮膚科学会

  • 日本アレルギー学会

  • 日本皮膚免疫アレルギー学会

  • 日本研究皮膚科学会

Research Projects

  • AHR agonistによるSLE皮疹の新たな治療薬の開発

    Grant number:24K19176  2024 - 2026

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Early-Career Scientists

    冬野 洋子

      More details

    Authorship:Principal investigator  Grant type:Scientific research funding

    全身性エリテマトーデス(SLE)の治療は、これまでステロイド内服などの免疫抑制剤が治療の主体であったが、近年ステロイドを減薬させることができるような、長期的に安全な新規治療薬の開発が望まれている。炎症性皮膚疾患の新たな治療ターゲットとして、AHR(Aryl hydrocarbon receptor; 芳香族炭化水素受容体)が注目されている。本研究ではAHRをターゲットとしたSLE皮疹に対する新たな治療法の開発を目指す。

    CiNii Research

  • Novel therapy targeting autophagy/LAP balance in SLE skin eruption

    Grant number:22K16265  2022 - 2023

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Early-Career Scientists

    Fuyuno Yoko

      More details

    Authorship:Principal investigator  Grant type:Scientific research funding

    The activation kinetics of the AHR, NRF2, and EGFR pathways were examined in NHEK when autophagy was induced, inhibited, or LAP inhibited. It was determined that CYP1A1 tended to increase regardless of autophagy/LAP, which may be due to reagent characteristics, and that autophagy/LAP balance and activation of the AHR could not be evaluated with autophagy inducers/inhibitors or LAP inhibitors. Stimulation of keratinocytes with synthetic nucleic acid and IFNα resulted in the appearance of SLE skin rash-like signals. Further treatment with AHR ligand showed suppression of some of the above SLE-like skin rash signals.

    CiNii Research

Clinician qualification

  • Specialist

    Japanese Society of Allergology

  • Specialist

    The Japanese Dermatological Association

Year of medical license acquisition

  • 2006